During the CIFIT (China International Fair for Investment and Trade) starting on September 8, Xiamen will hold the high-level "Xiamen International Biomedical Industry Conference in 2021" with a focus on the latest market access trends, protein engineering design and structural optimization. Biomedicine and health industry is one of the 100 billion-worth industrial chains that are put priority on. An industrial cluster featuring medical instruments and diagnostic reagents has been formed. And in the fields of new vaccines, genetically engineered protein drugs, and chemical drug preparation improvement, it has a strong innovation capability. Xiamen's biomedical and health industry performed well last year and continues to maintain a strong momentum of development this year, with an estimated output value of 47.3 billion yuan in the first half of the year, up more than 20% y-o-y.